Abiopharma

New Form 144 - HYPERION DEFI, INC. Filed: 2025-07-22 AccNo: 0001959173-25-004681 Size: 8 KB

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-07-22 AccNo: 0001575872-25-000478 Size: 2 MB

Rosen Law Firm Encourages Replimune Group, Inc. Investors to Inquire About Securities Class Action Investigation – REPL

New Form S-8 - Microbot Medical Inc. Filed: 2025-07-21 AccNo: 0001641172-25-020457 Size: 627 KB

New Form 4 - Serina Therapeutics, Inc. Filed: 2025-07-22 AccNo: 0001708599-25-000074 Size: 8 KB

NKGen Biotech to Present at the Alzheimer’s Association International Conference 2025

New Form SCHEDULE 13G - 60 DEGREES PHARMACEUTICALS, INC. Filed: 2025-07-22 AccNo: 0001649553-25-000133 Size: 15 KB

New Form SCHEDULE 13G - BriaCell Therapeutics Corp. Filed: 2025-07-22 AccNo: 0001649553-25-000130 Size: 15 KB

New Form SCHEDULE 13G - Praxis Precision Medicines, Inc. Filed: 2025-07-22 AccNo: 0000950170-25-097436 Size: 19 KB

New Form 144 - Cencora, Inc. Filed: 2025-07-22 AccNo: 0001959173-25-004677 Size: 6 KB

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit with the Schall Law Firm

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

New Form SCHEDULE 13G - TEVA PHARMACEUTICAL INDUSTRIES LTD Filed: 2025-07-22 AccNo: 0001178913-25-002442 Size: 10 KB

HealthStream to Host Second Quarter 2025 Earnings Conference Call